Top Markets
Coin of the day
PRISM BioLab Co.,LTD PRISM BioLab Co.,LTD

PRISM BioLab Co.,LTD

206A
Rank in Stocks #26411
PRISM Pharma Co., Ltd. is a pharmaceutical enterprise dedicated to identifying... PRISM Pharma Co., Ltd. is a pharmaceutical enterprise dedicated to identifying and advancing small molecule compounds. Its core mission involves modulating protein-protein interactions. The company leverages a proprietary protein secondary structure mimetic library to regulate interactions between proteins within cells. A key product in its development pipeline is PRI-724, an anti-cancer CP/Catenin inhibitor. This drug targets both mature cancer cells and cancer stem cells, inducing them to transition from uncontrolled proliferation to differentiation. Hiroyuki Kouji founded the organization on November 2, 2006, and it is headquartered in Fujisawa, Japan.
Share Price
$1.10
Market Cap
$40.76M
Change (1 day)
3.68%
Change (1 year)
-13.12%
Country
JP
Trade PRISM BioLab Co.,LTD (206A)

Category

P/S ratio for PRISM BioLab Co.,LTD (206A)
P/S ratio as of 2026 TTM: 0
According to PRISM BioLab Co.,LTD latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for PRISM BioLab Co.,LTD from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
10.17 -
US
10.13 -
NL
2.95 -
AU
- -
CH
11.28 -
US